New Key Statistics Module, Z-Score and F-Score
SZSE:002873 Key Ratios
Market Cap ¥ M | 1,738.92 |
Enterprise Value ¥ M | 2,311.69 |
P/E(ttm) | 26.41 |
PE Ratio without NRI | 26.78 |
Forward PE Ratio | -- |
Price/Book | 1.73 |
Price/Sales | 2.02 |
Price/Free Cash Flow | 106.76 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.35 |
Revenue (TTM) ¥ M | 922.00 |
EPS (TTM) ¥ | 0.29 |
Beneish M-Score | -2.68 |
10-y EBITDA Growth Rate % | 7.70 |
5-y EBITDA Growth Rate % | 14.30 |
y-y EBITDA Growth Rate % | -23.00 |
EV-to-EBIT | 23.95 |
EV-to-EBITDA | 23.95 |
PEG | 1.87 |
Shares Outstanding M | 229.41 |
Net Margin (%) | 7.73 |
Operating Margin % | 10.53 |
Pre-tax Margin (%) | 9.17 |
Quick Ratio | 0.67 |
Current Ratio | 0.97 |
ROA % (ttm) | 3.65 |
ROE % (ttm) | 6.33 |
ROIC % (ttm) | 4.76 |
Dividend Yield % | 0.92 |
Altman Z-Score | 2.23 |
SZSE:002873 Number of Guru Trades
SZSE:002873 Volume of Guru Trades
Gurus Latest Trades with SZSE:002873
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002873 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guiyang Xintian Pharmaceutical Co Ltd Insider Transactions
No Available Data